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Background: Rapid diagnostic tests for malaria (RDTs) allow accurate diagnosis and prompt treatment. Validation of
their usefulness in travellers with fever was needed. The safety of a strategy to diagnose falciparum malaria based
on RDT followed by immediate or delayed microscopy reading at first attendance was evaluated in one referral
hospital in Switzerland.
Methods: A retrospective study was conducted in the outpatient clinic and emergency ward of University Hospital,
covering a period of eight years (1999–2007). The study was conducted in the outpatient clinic and emergency
ward of University Hospital. All adults suspected of malaria with a diagnostic test performed were included. RDT
and microscopy as immediate tests were performed during working hours, and RDT as immediate test and delayed
microscopy reading out of laboratory working hours. The main outcome measure was occurrence of specific
complications in RDT negative and RDT positive adults.
Results: 2,139 patients were recruited. 1987 had both initial RDT and blood smear (BS) result negative. Among
those, 2/1987 (0.1%) developed uncomplicated malaria with both RDT and BS positive on day 1 and day 6
respectively. Among the 152 patients initially malaria positive, 137 had both RDT and BS positive, four only BS
positive and five only RDT positive (PCR confirmed) (six had only one test performed). None of the four initially RDT
negative/BS positive and none of the five initially BS negative/RDT positive developed severe malaria while 6/137
of both RDT and BS positive did so. The use of RDT allowed a reduction of a median of 2.1 hours to get a first
malaria test result.
Conclusions: A malaria diagnostic strategy based on RDTs and a delayed BS is safe in non-immune populations,
and shortens the time to first malaria test result.
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In many industrialized countries, imported malaria
accounts for a significant burden of disease and mortal-
ity every year [1-3]. Prompt treatment of malaria is
essential because of its potentially rapid and fatal course.
Quick documentation of Plasmodium parasitaemia in
the blood is the mainstay to initiate appropriate treat-
ment. However, accurate diagnosis remains a challenge.
Diagnosis by microscopy is still considered as the gold* Correspondence: isabelle.rossi@bluewin.ch
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reproduction in any medium, provided the orstandard, but turnaround time often exceeds 2–3 hours
and accuracy is acceptable only when performed by
experienced microscopists [4,5]. Rapid diagnostic tests
for malaria (RDTs) have recently emerged as an alterna-
tive to microscopy [6]. Their accuracy in endemic and
non-endemic countries has been extensively evaluated
and confirmed in three meta-analyses [7-9]. Further-
more, their performance, even in the industrialized
world, is often superior to blood smears (BS) performed
under routine clinical laboratory conditions [10].
Based on the available evidence of excellent diagnostic
performance of RDTs, insufficient sensitivity of routine
microscopy, especially in non immune travellers [11],d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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predictors of malaria [12], a new strategy for the diagno-
sis of malaria in febrile patients returning from endemic
countries was introduced in October 1999. The strategy
was based on RDT as immediate test and delayed
microscopy in patients without danger signs attending
out of hours.
In this report, an evaluation of the safety (incidence of
complications or death) of a malaria diagnostic strategy
based on RDTs and implemented under routine condi-
tions for returning travellers and migrants in a non en-
demic country, over an eight-year period is provided.
The safety of using RDTs as main diagnostic tool has
already been demonstrated in many patients of semi-
immune populations in endemic countries [13-15].
Methods
Subjects and study setting
Files of all adult patients (≥ 16 years) attending the out-
patient clinic and emergency ward of the University
Hospital in Lausanne between October 1999 and August
2007 who underwent a malaria test were reviewed. Chil-
dren were not included since they are managed in a dif-
ferent location. Only patients who had a positive RDT
for falciparum only or mixte infection were included in
the study. Indeed, severe malaria due to non-falciparum
mono-infection is rare and, at the time of the study, the
sensitivity for Plasmodium vivax of available RDT
brands was rather low.
Strategy assessed
The diagnostic strategy included different procedures
determined by the opening hours of the parasitology
laboratory of the University Hospital. All patients
returning from a malaria endemic country and com-
plaining of fever were to undergo first an RDT. If they
presented during working hours, the microscopical
examination was to be performed immediately or at least
within three hours. Out of hours and during weekends,
patients were to undergo just an RDT if there was no
danger sign. If the RDT was negative, the microscopy
reading was delayed until the next day (up to 14 hours).
If there was a danger sign at first attendance, patients
were to undergo an RDT followed by a microscopical
examination within three hours, irrespective of para-
sitology laboratory opening hours. The presence of
thrombocytopaenia <100 G/l was also considered suffi-
cient to warrant an immediate BS, since it has proved
to be a strong diagnostic predictor of malaria (positive
likelihood ratio of 11) [12,16]. When the RDT was posi-
tive, the patient was to be given immediately appropriate
anti-malarial treatment (oral or intravenous) according to
the presence/absence of severe malaria and the micro-
scopical examination was to follow immediately (seedetailed strategy in Figure 1). The standard treatment
for uncomplicated malaria was mefloquine (LariamW,
Roche; MephaquineW, Mepha) from 1999–2002 and
the combination of artemether/lumefantrine (RiametW,
Novartis) from 2003 onwards [17]. For severe malaria
the standard treatment was quinine plus doxycycline
intravenously all along the study. The treatment was
adjusted following reception of the microscopy result
(switch to intravenous treatment when parasite density
was >2%). RDTs used were ICT Malaria Pf/Pv (ICT-
Amrad, Sydney, Australia) until January 2006 and then
OptiMALW (Diamed, Cressier, Switzerland). Regarding
microscopy, only thin smears were available at the time
of the study, which were declared negative after reading
during 20 minutes.
Definitions
A case of Plasmodium falciparum malaria was defined
as a patient with at least one of the tests (RDT or micro-
scopical examination) positive for P. falciparum only
or mixed infection, irrespective of any other incidental
diagnosis. Patients with danger sign(s) were defined as
patients having at least one of the following signs: poor
general condition, any neurological sign, respiratory
distress, hypotension (systolic PA < 90 mmHg), shock
(systolic PA < 70 mmHg), severe renal insufficiency (cre-
atinine >250 μmol/l), severe hepatic insufficiency (INR ≥
1.5 and any degree of mental alteration), severe anaemia
(< 80 g/dl), bleeding sign, hypoglycaemia (<3.9 mmol/l).
These criteria, plus a few others (repeated vomiting, high
parasite density (>2%), failure with previous anti-
malarial treatment, poor compliance, alone at home,
pregnancy) are also used for deciding about admission
of the patient. Patient who do not fulfill these criteria
are managed on an ambulatory base [18]. Complications
were defined as the new onset of danger signs or pro-
gression to severe malaria (according to the WHO case
definition malaria), [19] that was not present at enroll-
ment and occurred during follow-up.
Procedures for retrospective analysis
Demographic information and details on time of avail-
ability of RDT test result and microscopy result were
extracted from patient’s file and laboratory database. The
time between RDT and microscopy result availability
could then be calculated. Because the guidelines in the
University Hospital in Lausanne specify that the anti-
malarial treatment should be initiated as soon as the first
malaria test is positive, the latter corresponds closely to
the time to onset of appropriate treatment saved when
using RDT rather than microscopy alone. To assess
safety, the occurrence of death (any cause) during
follow-up in both malaria and non-malaria patients as
well as the occurrence of severe malaria (according to
Figure 1 Malaria diagnostic strategy during and out of working hours.
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lated. The number of initially negative patients (by RDT
and microscopy) who turned positive during follow-up
(so called ‘missed malaria’), and the consequence on out-
come were also recorded.
Detailed clinical information was extracted from the
file for all patients who were once malaria positive to as-
certain severe case definition. Follow-up was done up tothe last consultation (negative BS and recovery or recov-
ery only for those who were RDT positive but always
microscopy negative). Such detailed clinical assessment
was not done for patients always malaria negative since
this was not related to study objectives. To ascertain that
none of these latter patients died of malaria outside the
University hospital (at home or elsewhere), all death
records of the Federal Office of Statistics that mentioned
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These data were cross-checked with malaria death records
of the Federal and Cantonal Office of Public Health.
To assess the impact on the safety (occurrence of
severe malaria) of full compliance or not to the diagnos-
tic strategy, health outcomes according to the tests done
(RDT or microscopy) and timelines (within 3 or 14
hours) depending on arrival (working hours or out of
hours) for the malaria positive patients were analysed.Results
Between October 1999 and August 2007 a total of 2,190
patients older than 16 years were tested for malaria
(as per laboratory records). 41 were excluded because
they were positive for a non-falciparum species only.
10 patients positive for P. falciparum were also excluded,
six because clinical files could not be retrieved and four
because the pre-defined diagnostic strategy could not
be used. For two of them, diagnosis was indeed for-
tuitous during examination of a blood smear; two other
cases had already taken a full treatment (one had
only gametocytes, the other a positive RDT). None of
these four excluded cases developed severe malaria.
2,139 patients were thus included in the present retro-
spective analysis.
The demographic characteristics of the 154 falci-
parum malaria patients were as follows: 60% were men;
mean age was 38.9 years; 79% were returning travellers,
9% migrants and 12% expatriates; 97% contracted
malaria in sub-Saharan Africa. Among the 126 travellers
who should have taken malaria chemoprophylaxis
according to the recommendations, only three had regu-
larly taken the recommended chemoprophylactic agent.
Clinically, the mean duration of symptoms before con-
sultation was 3.9 days; 31% had a maximal parasite dens-
ity of <0.1%, 36% of 0.1-0.9%, 24% of 1.0-4.9 and 8%
≥5%; 25% had at least one co-morbidity; 30% had at
least one danger sign and 17.5% had severe malaria at
first attendance.Malaria test results at first attendance
Initial malaria tests results are pictured in Figure 2.
1,987 (92.9%) had both RDT and BS result negative. 152
(7.6%) were malaria positive: 137 by RDT and micros-
copy, four by microscopy only and five by RDT only
(one was tested by RDT only and five by microscopy
only). Full agreement between the two methods was thus
94%. The four patients who were negative by RDT but
positive by microscopy had a parasite density of 0.4% for
one and <0.1% for the other three. The five patients who
were positive by RDT but negative by microscopy
were all confirmed positive by PCR performed at a later
stage [20].Malaria occurrence during follow-up and health outcomes
according to initial test result
Malaria occurrence during follow-up of initially negative
patients and number of severe malaria and deaths accord-
ing to initial malaria test results are detailed in Figure 3.
Among the 1,987 initially negative patients, two (0.1%)
developed uncomplicated malaria with both RDT and BS
positive on day 1 and day 6 respectively; they both
recovered uneventfully. One out of 1,987 negative
patient died; both RDT and BS results were always nega-
tive; the cause of death was rickettsiosis (case report
published elsewhere) [21]. Among the 152 patients
malaria positive at first attendance, no death occurred.
None of the four initially RDT negative /BS positive
(one had danger signs upon admission) and five ini-
tially RDT positive /BS negative (one had danger signs
upon admission) developed severe malaria during
follow-up while 6/137 of both RDT and BS positive did
so (43/137 had already danger signs upon admission).
Of note, one patient with RDT positive but negative BS
result had severe malaria at the time of diagnosis (three
days after admission). He was not suspected of malaria
on the day of admission, even if he was coming back
from expatriation in Democratic Republic of Congo,
since he was hospitalized for a surgical procedure (ex-
ploratory laparotomy). Three days after admission and
surgical procedure, he developed fever and impairment
of consciousness. An RDT at that moment was done
and found positive. Treatment with intravenous quinine
was started but wrongly interrupted the day after, due
to the fact that clinicians did not trust the RDT posi-
tive result in the presence of a negative BS. Fifteen
days later, the patient developed again signs of severe
malaria and the BS showed a parasitaemia of 4.1%. Re-
covery was uneventful after appropriate treatment.
Time between availability of RDT result and
microscopy result
Information to calculate the time between RDT result
and microscopy result was available for 125 (85.6%)
malaria positive cases. The median time to get the BS
result after having had the RDT result was 2.1 hours (IQ
1.5-3.6 hours, range 32 minutes-72.8 hours) [2.0 hours
(IQ 1.6-2.6 hours, range 32 minutes-72.8 hours) during
laboratory working hours and 2.1 hours (IQ 1.4-5.1 hours,
range 33 minutes-70.8 hours) out of hours]. Of note the
median time between the blood sample and RDT result
was 15 minutes (IQ 15–50 minutes, range 15 minutes-
5.8 hours).
Compliance to the timelines defined by the diagnostic
strategy
Overall non-compliance to timelines defined in the diag-
nostic strategy was 31.5% (40/127). It was 20% (10/50)
All confirmed 
P. falciparum by PCR
45 137
MicroscopyRDT
2139 patients included
1987 Negative
51
Figure 2 Malaria test results at first attendance: concordance between RDT and microscopy results.
Rossi et al. Malaria Journal 2012, 11:377 Page 5 of 7
http://www.malariajournal.com/content/11/1/377for patients attending during working hours and 39%
(30/77) for those attending out of hours (p = 0.04). Non-
compliance to timelines was 29% (20/69) for patients
with danger signs and 34.5% (20/58) for those without
danger signs (p = 0.64). Non-compliance to timeline
recommendations (for those with or without danger
signs) did not affect heath outcome.2139 t
for ma
152 positive 
by RDT or BS *
5
RDT+BS- 
(PCR+)
0 developed 
severe malaria
No death 
137
RDT+ BS+
6 developed 
severe malaria
No death 
4
RDT-BS+
0 developed 
severe malaria
No death 
Figure 3 Malaria occurrence during follow-up and health outcomes a
by microscopy only; the six recovered unventfully (not presented in the FigRelation of timelines to occurrence of severe malaria
Median time before getting a BS result was 2.1 hours
(IQ 1.4-3.5, range 32 minutes-72.8 hours) for the cases
without any complication and 3.2 hours (IQ 2.1-16.7,
range 1.6-27.8) for the six cases who developed severe
malaria after admission (p = 0.14). Among the four
patients with negative RDT but positive microscopy, theested 
laria
1987 negative
RDT-BS -
2 developed 
uncomplicated malaria 
RDT+ BS+ 
(after 1 and 6 days) 
0 developed 
severe malaria
No death 
1984 recovered 
1 death 
RDT-BS-
Rickettsiosis
ccording to initial test results. One was tested by RDT only and five
ures).
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37.7 and 70.8 hours. One of the four had a danger signs
at first attendance and none developed severe malaria
(as mentioned above).
Among the six cases that developed severe malaria
after admission, all six had a positive RDT and BS at first
testing. Three had microscopy reading within three
hours after RDT result; for the other three, the delay
to get microscopy results was respectively of 4.3, 17 and
27 hours. One had no danger sign, three had at least one
danger sign at first attendance and another two
had thrombocytopaenia <100 G/L. Among those with
danger signs or thrombocytopaenia, all except one
received intravenous quinine at first place. All six
cases who developed severe malaria after admission
recovered uneventfully.
Discussion
The present study provides, for the first time, evidence
that a malaria diagnostic strategy based on a RDT fol-
lowed by immediate or delayed microscopy reading at
first attendance is safe and does not expose travellers or
migrants to an increased risk of severe malaria or death.
These findings can probably be generalized to most
setting in non-endemic countries since they derive from
data collected in predominantly non-immune patient
population under routine clinical and laboratory condi-
tions of an ordinary outpatient clinical and emergency
hospital ward. No patient with a negative RDT devel-
oped severe malaria, despite a planned delay before get-
ting the blood smear results out of hours. This was
true even when established timelines between RDT and
microscopy were not complied to. The use of RDTs was
not associated with the development of complications
since all 6 cases who developed severe malaria after
admission had a positive RDT at first testing. The avail-
ability nowadays of artemisinin-based combination ther-
apy (ACT) for the treatment of uncomplicated malaria
renders the strategy with RDT even safer since ACT is
very effective and well-tolerated [17,22]. ACT should be
given in the outpatient department or emergency ward
immediately after a positive RDT result while waiting for
the BS result, even in uncomplicated cases. Similarly,
quinine should be administered straight after a positive
RDT result for severe cases.
Even if the study was not designed to validate the ac-
curacy and performance of RDTs, which has already
been extensively demonstrated, RDTs were as good as
microscopy to diagnose malaria. Indeed 5 malaria diag-
noses were based on positive RDT results only (negative
blood slide) and 4 on blood smear results only (negative
RDT result). Recently, Gillet et al. [23,24] and Luchavez
et al. [25] demonstrated that the prozone effect (false-
negative or false-low results, due to an excess of eitherantigen or antibody) exists, but has so far only been
described with histidine-rich protein 2 tests [23,24].
Negative results were rare compared to an increase in test
line intensity after dilution. In our study, none of the
negative RDT results was explained by the prozone effect.
This strategy of performing an immediate blood smear
in the presence of danger signs or a thrombocytes count
< 100 G/l (higher pre-test probability) should prevent
delay in the diagnosis of malaria in case of false negative
RDT result in the presence of hyperparasitaemia.
Diagnostic strategies based on RDT have been adopted
in other centres managing non-immune patients [10,26]
but, this is the first study assessing the safety of such
strategy. Because of the retrospective design of the study,
we were able to assess the strategy under routine clinical
and laboratory practice. As imported malaria is a rare
disease and severe malaria even rarer, it was not possible
to perform a non-inferiority trial comparing the strategy
with and without RDT. Also there are concerns not to
use RDTs in a setting where not all laboratory tech-
nicians are familiar with malaria parasites, especially out
of hours, which might have resulted in missed malaria,
and hence higher rate of complications.
The less rigorous follow-up of the malaria negative
patients is a limitation in the overall assessment. How-
ever, it is highly unlikely that secondary malaria cases
were missed after having attended the outpatient clinic
since feverish patients are advised to come back daily to
repeat malaria tests, especially so if symptoms persist or
worsen. In addition, the University Hospital in Lausanne
has a long tradition of reference centre for travel related
diseases in the area and is easily accessible. At least, sec-
ondary malaria deaths that would have occurred outside
the hospital have been virtually excluded by our investi-
gation of malaria death records in the region. This study
was undertaken in one hospital only and should be
repeated in different settings to accumulate more evi-
dence. Since non-falciparum malaria patients and chil-
dren were excluded, the safety of this strategy should be
confirmed for malaria due to other species (especially so
since RDT of last generation do detect vivax with excel-
lent sensitivity) and in a paediatric population [27].
In conclusion, this study - conducted in a routine clin-
ical and laboratory non-endemic setting without 24-hour
expert microscopy available – provides some evidence
that a malaria diagnostic strategy based on RDTs fol-
lowed by immediate or delayed microscopy reading is
safe. Indeed no patients with a negative RDT developed
severe malaria or died. This study adds information
about the safety of a malaria diagnostic strategy based
on RDTs, of which accuracy and performance have been
extensively demonstrated. There was also a clear benefit
of using RDT, as it allowed decreasing significantly the
delay before getting a test result (and thus onset of
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hours and increasing overall sensitivity when combined
with microscopy. The results of this analysis provide evi-
dence and lessons for considering large-scale implemen-
tation of malaria diagnostic strategies that include RDTs
in non-endemic settings.
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